Abstract
Autoimmune pancreatitis (AIP) is a pancreatic manifestation of an IgG4-related disease (IgG4-RD). AIP lacks disease-specific biomarkers, and therefore, it is difficult to distinguish AIP from malignancies, especially pancreatic cancer. In this review, we have summarized the latest findings on potential diagnostic biomarkers for AIP. Many investigations have been conducted, but no specific biomarkers for AIP are identified. Therefore, further studies are required to identify accurate diagnostic biomarkers for AIP.
Author supplied keywords
Cite
CITATION STYLE
Yokode, M., Shiokawa, M., & Kodama, Y. (2021). Review of diagnostic biomarkers in autoimmune pancreatitis: Where are we now? Diagnostics. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/diagnostics11050770
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.